Female patient talking to doctor. There was no significant difference in event-free survival between the carboplatin-containing arms. Adding carboplatin to neoadjuvant paclitaxel significantly ...
This trial is looking at a new way of giving carboplatin chemotherapy called adaptive therapy. It is comparing this to having standard carboplatin chemotherapy for ovarian cancer. It is for women ...
Threshold Dose-Response Association Between Alcohol Consumption and Risk of Young-Onset Pancreatic Cancer: A Nationwide Korean Cohort Study of Young Adults Age 20-39 Years Neoadjuvant approaches for ...
New York, NY (August 20, 2025) – A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy everolimus to standard carboplatin ...
SAN ANTONIO — The addition of carboplatin to a standard neoadjuvant chemotherapy regimen significantly improves disease-free or event-free survival in patients with early-stage triple-negative breast ...
Incyte Announces the European Commission Approval of Zynyz (retifanlimab) for First-Line Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC) ...
Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors Further trials are warranted that evaluate adding a 10 mg dose of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results